| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥27.98B | +34.6% |
| Gross profit | ¥3.61B | — |
| Operating income | ¥1.05B | — |
| Net income | ¥0.96B | +144.5% |
| Gross margin | 12.9% | Net margin 3.4% |
| Revenue Q/Q | +44.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥24.38B | 87.1% |
| R&D | ¥1.20B | 4.3% |
| SG&A | ¥1.24B | 4.4% |
| Tax & other | ¥0.09B | 0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华东医药 ・ 山金国际 ・ 浪潮信息 ・ 华工科技 ・ 华润三九 ・ 中国铀业 ・ 国货航 ・ 招商公路 ・ 招商蛇口 ・ 新和成 ・ 分众传媒 ・ 思源电气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies